Home | Articles
Published on:September 2019
Indian Journal of Pharmaceutical Education and Research, 2019; 53(4):569-576
Review Article | doi:10.5530/ijper.53.4.118

Prevalence and Pharmacotherapeutic Management of Pediatric Psoriasis–A Descriptive Review

Authors and affiliation (s):

Ahmed A Albarraq, Saad S. Alqahtani, Sarfaraz Ahmad, David Banji*,

Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jizan, Saudi Arabia


Psoriasis is an auto-immune chronic inflammatory skin disease, which affects about 3.5% of the world’s population. Prevalence of psoriasis among children aged 0 to 18 years is 1% in the United State of America, 5.3% in eastern Saudi Arabia and is on constant rise in other parts of the world. An effective treatment of psoriasis in children may often be challenging mainly because of the lack of established therapeutic guidelines. The objective of this review, therefore, is to provide an update on the prevalence and the pharmacotherapeutic management of pediatric psoriasis, which could be beneficial to clinical pharmacists and other healthcare workers. This multifactorial papulosquamous disorder is linked with the genetic makeup of an individual although the various risk factors like obesity, stress, emotional imbalance, psychological disturbances, cold weather, skin irritation, infection in the respiratory tract and the presence of hemolytic streptococcus could trigger psoriasis. Plaque psoriasis is the most common; but, guttate, pustular disease, erythrodermic (red skin) and rheumatoid psoriasis diseases are also noticed in children. The successful approach for treating psoriasis in children depends on the precise selection of line of therapy on case-by-case basis to enhance benefit-risk ratio, with careful attention of its impact on the patient and family. Therefore, treatment of pediatric psoriasis must be rationalized based on the type and intensity of the disease to reduce probable side effects of drugs in children.

Key words: Psoriasis, Pediatric, Rational, Autoimmune disease, Dermatological, Prevalence.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs